ORBi: Detailled Reference

Article (Scientific journals)

Effect of sodium-glucose cotransporter type 2 inhibitors on liver fat in patients with type 2 diabetes: hepatic beyond cardiovascular and renal protection?

Scheen, André

2018 • In Annals of Translational Medicine, 6 (Suppl 1), p. 68

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/235353

DOI
10.21037/atm.2018.10.39

PubMed
30613643

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

2018 ATM-2018-158-author-proof1.pdf

Publisher postprint (136.15 kB)

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Abstract :

[en] Edito

Disciplines :

Gastroenterology & hepatology
Pharmacy, pharmacology & toxicology
Endocrinology, metabolism & nutrition

Author, co-author :

Scheen, André ; Université de Liège - ULiège > Département des sciences cliniques > Département des sciences cliniques

Language :

English

Title :

Effect of sodium-glucose cotransporter type 2 inhibitors on liver fat in patients with type 2 diabetes: hepatic beyond cardiovascular and renal protection?

Publication date :

2018

Journal title :

Annals of Translational Medicine

ISSN :

2305-5839

eISSN :

2305-5847

Publisher :

AME Publications, Hong Kong, China

Volume :

6

Issue :

Suppl 1

Pages :

S68

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 10 May 2019

Statistics

Number of views

33 (2 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics

OpenCitations

8

Bibliography

Similar publications